FORMATION OF ²³⁶PU, ²³⁷PU AND ²³⁸PU ISOTOPES BY ³HE-INDUCED NUCLEAR REACTIONS ON URANIUMAALTONEN J; HAAPARANTA M; KULHA M et al.1981; J. RADIOANAL. CHEM.; ISSN 0022-4081; CHE; DA. 1981; VOL. 64; NO 1-2; PP. 73-82; BIBL. 6 REF.Article

Biodistribution and scintigraphy of ¹¹C-toremifene in rats bearing DMBA-induced mammary carcinomaKANGAS, L; HAAPARANTA, M; PAUL, R et al.Pharmacology & toxicology. 1989, Vol 64, Num 4, pp 373-377, issn 0901-9928Article

Uncoupling of fatty acid and glucose metabolism in malignant lymphoma : a PET studyNUUTINEN, J; MINN, H; BERGMAN, J et al.British journal of cancer. 1999, Vol 80, Num 3-4, pp 513-518, issn 0007-0920Article

Pharmacokinetics and metabolism of 2-[¹⁸F]fluoro-2-deoxyy-D-glucose (FDG) in mammary tumors of antiestrogen-treated ratsHAAPARANTA, M; PAUL, R; HUOVINEN, R et al.Nuclear medicine and biology. 1995, Vol 22, Num 4, pp 483-489, issn 0969-8051Article

Scintigraphy with [¹⁸F] 2-fluoro-2-deoxy-D-glucose of cancer patientsPAUL, R; ROEDA, D; JOHANSSON, R et al.International journal of nuclear medicine & biology. 1986, Vol 13, Num 1, pp 7-12, issn 0047-0740Article

Metabolism of 2-[¹⁸F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studiesSUOLINNA, E.-M; HAAPARANTA, M; PAUL, R et al.Nuclear medicine and biology. 1986, Vol 13, Num 5, pp 577-581, issn 0969-8051Article

Cognitive impairment and the brain dopaminergic system in Parkinson : Disease [¹⁸F]fluorodopa positron emission tomographic studyRINNE, J. O; PORTIN, R; RUOTTINEN, H et al.Archives of neurology (Chicago). 2000, Vol 57, Num 4, pp 470-475, issn 0003-9942Article

Usefulness of a dopamine transporter PET ligand [¹⁸F] β-CFT in assessing disability in Parkinson's diseaseRINNE, J. O; RUOTTINEN, H; BERGMAN, J et al.Journal of neurology, neurosurgery and psychiatry. 1999, Vol 67, Num 6, pp 737-741, issn 0022-3050Conference Paper

Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acidMÄKI, M. T; HAAPARANTA, M; NUUTILA, P et al.The Journal of nuclear medicine (1978). 1998, Vol 39, Num 8, pp 1320-1327, issn 0161-5505Article

FDG-PET in early infancy : simplified quantification methods to measure cerebral glucose utilizationSUHONEN-POLVI, H; RUOTSALAINEN, U; KINNALA, A et al.The Journal of nuclear medicine (1978). 1995, Vol 36, Num 7, pp 1249-1254, issn 0161-5505Article

Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomographyBLOMQVIST, G; SEITZ, R. J; SJÖGREN, I et al.Acta physiologica scandinavica. 1994, Vol 151, Num 1, pp 29-43, issn 0001-6772Article

Acute effects of celiprolol on muscle blood flow and insulin sensitivity : studies using [¹⁵O]-water, [¹⁸F]-fluorodeoxyglucose and positron emission tomographyMALMINIEMI, K; LAINE, H; KNUUTI, M. J et al.European journal of clinical pharmacology. 1997, Vol 52, Num 1, pp 19-26, issn 0031-6970Article

[¹⁸F]Fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosisRUOTTINEN, H. M; RINNE, J. O; HAAPARANTA, M et al.Journal of neurology, neurosurgery and psychiatry. 1997, Vol 62, Num 6, pp 622-625, issn 0022-3050Article

Gender and insulin sensitivity in the heart and in skeletal muscles : studies using positron emission tomographyNUUTILA, P; KNUUTI, M. J; MÄKI, M et al.Diabetes (New York, NY). 1995, Vol 44, Num 1, pp 31-36, issn 0012-1797Article

[¹⁸F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462)LAIHINEN, A; RINNE, J. O; RINNE, U. K et al.Neurology. 1992, Vol 42, Num 1, pp 199-203, issn 0028-3878Article

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's diseaseRINNE, J. O; LAIHINEN, A; NAGREN, K et al.Journal of neuroscience research. 1990, Vol 27, Num 4, pp 494-499, issn 0360-4012, 6 p.Article

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomographyLAAKSO, A; VILKMAN, H; ALAKARE, B et al.The American journal of psychiatry. 2000, Vol 157, Num 2, pp 269-271, issn 0002-953XArticle

Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomographyVOIPIO-PULKII, L. M; NUUTILA, P; KNUUTI, M. J et al.JNM. The journal of nuclear medicine (1990). 1993, Vol 34, Num 12, pp 2064-2067Article

An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndromeRUOTTINEN, H. M; PARTINEN, M; HUBLIN, C et al.Neurology. 2000, Vol 54, Num 2, pp 502-504, issn 0028-3878Article

Estimated radiation dose to the newborn in FDG-PET studiesRUOTSALAINEN, U; SUHONEN-POLVI, H; ERONEN, E et al.The Journal of nuclear medicine (1978). 1996, Vol 37, Num 2, pp 387-393, issn 0161-5505Article

[¹⁸F]fluorodeoxyglucose uptake in tumors : kinetic vs. steady-state methods with reference to plasma insulinMINN, H; LESKINEN-KALLIO, S; LINDHOLM, P et al.Journal of computer assisted tomography. 1993, Vol 17, Num 1, pp 115-123, issn 0363-8715Article

Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [¹⁸F]6-fluorodopa PETLAIHINEN, A; RUOTTINEN, H; RINNE, J. O et al.Journal of neurology. Supplement. 2000, Vol 247, Num 2, pp 110-113, issn 0939-1517Conference Paper

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophreniaHIETALA, J; SYVÄLAHTI, E; RUOTSALAINEN, U et al.Schizophrenia research. 1999, Vol 35, Num 1, pp 41-50, issn 0920-9964Article

Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulationTAKALA, T. O; NUUTILA, P; KAPANEN, J et al.American journal of physiology. Endocrinology and metabolism. 1999, Vol 40, Num 4, pp E585-E590, issn 0193-1849Article

Cerebral metabolic rate for glucose during the first six months of life : and FDG positron emission tomography studyKINNALA, A; SUHONEN-POLVI, H; WEGELIUS, U et al.Archives of disease in childhood. 1996, Vol 74, Num 3, pp F153-F157, issn 0003-9888Article